Lupin Limited has informed the Exchange regarding a press release dated January 07, 2022, titled "Lupin launches Molnupiravir under the brand name Molnulup for the treatment of COVID-19 in adults in India.".
Press Release Jan 07 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Dec 25 2021
- Press Release Dec 24 2021
- Press Release (Revised) Dec 14 2021
- Press Release Dec 14 2021
- Press Release Dec 10 2021
Later from Lupin
- Press Release Jan 19 2022
- Press Release Jan 27 2022
- Press Release Feb 01 2022
- Press Release Feb 03 2022
- Press Release Feb 08 2022
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin